$3.55
4.11% yesterday
Nasdaq, May 16, 10:11 pm CET
ISIN
US18914F1030
Symbol
CLOV
Sector
Industry

Clover Health Investments Corp - Ordinary Shares - Class A Stock price

$3.55
-0.14 3.79% 1M
+0.34 10.59% 6M
+0.40 12.70% YTD
+2.62 280.13% 1Y
+0.96 37.07% 3Y
-6.65 65.20% 5Y
-6.65 65.20% 10Y
Nasdaq, Closing price Fri, May 16 2025
+0.14 4.11%
ISIN
US18914F1030
Symbol
CLOV
Sector
Industry

Key metrics

Market capitalization $1.81b
Enterprise Value $1.65b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.11
P/S ratio (TTM) P/S ratio 1.22
P/B ratio (TTM) P/B ratio 5.08
Revenue growth (TTM) Revenue growth -19.54%
Revenue (TTM) Revenue $1.49b
EBIT (operating result TTM) EBIT $-24.44m
Free Cash Flow (TTM) Free Cash Flow $-8.68m
EPS (TTM) EPS $-0.05
P/E forward negative
P/S forward 0.97
EV/Sales forward 0.89
Short interest 3.39%
Show more

Is Clover Health Investments Corp - Ordinary Shares - Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,785 stocks worldwide.

Clover Health Investments Corp - Ordinary Shares - Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Clover Health Investments Corp - Ordinary Shares - Class A forecast:

2x Buy
50%
2x Hold
50%

Analyst Opinions

4 Analysts have issued a Clover Health Investments Corp - Ordinary Shares - Class A forecast:

Buy
50%
Hold
50%

Financial data from Clover Health Investments Corp - Ordinary Shares - Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,486 1,486
20% 20%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 415 415
1% 1%
28%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization 1.48 1.48
42% 42%
0%
EBIT (Operating Income) EBIT -24 -24
82% 82%
-2%
Net Profit -25 -25
84% 84%
-2%

In millions USD.

Don't miss a Thing! We will send you all news about Clover Health Investments Corp - Ordinary Shares - Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Clover Health Investments Corp - Ordinary Shares - Class A Stock News

Positive
Seeking Alpha
6 days ago
Clover reported impressive Q1 earnings with robust topline growth and improving profitability metrics thanks to a 30% YoY increase in its member base. Clover could see $95 million in additional revenues in FY 2026 without any member growth as a result of CMS increasing MA payouts by 5.1%. With Clover set to be eligible for a 5% quality bonus in 2026 thanks to its 4-star rating, I expect it to r...
Neutral
Seeking Alpha
10 days ago
Clover Health Investments, Corp. (NASDAQ:CLOV ) Q1 2025 Earnings Conference Call May 6, 2025 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Andrew Toy - Chief Executive Officer Peter Kuipers - Chief Financial Officer Conference Call Participants Jonathan Yong - UBS Matt Hewitt - Craig-Hallum Capital Richard Close - Canaccord Genuity Operator Ladies and gentlemen, good afterno...
Neutral
GlobeNewsWire
11 days ago
First quarter 2025 Medicare Advantage membership of 103,418, up 30% year-over-year First quarter 2025 Total revenues of $462 million, up 33% year-over-year Medicare Advantage medical costs are in line with expectations, underscoring the strength of Clover's technology-first care management model Meaningful improvement across first quarter 2025 profitability metrics: GAAP Net loss of $1 million,...
More Clover Health Investments Corp - Ordinary Shares - Class A News

Company Profile

Clover Health Investments Corp. provides healthcare insurance services. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. The company was founded in 2014 and is headquartered in Franklin, TN.

Head office United States
CEO Andrew Toy
Employees 570
Founded 2014
Website www.cloverhealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today